Draper Asset Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$1.65M |
| 2 |
Uber
UBER
|
+$865K |
| 3 |
Eli Lilly
LLY
|
+$574K |
| 4 |
Costco
COST
|
+$546K |
| 5 |
Johnson & Johnson
JNJ
|
+$378K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$889K |
| 2 |
DocGo
DCGO
|
+$236K |
| 3 |
Vail Resorts
MTN
|
+$196K |
| 4 |
Amazon
AMZN
|
+$131K |
| 5 |
Wheels Up
UP
|
+$69K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 50.21% |
| 2 | Consumer Discretionary | 28.16% |
| 3 | Communication Services | 12.41% |
| 4 | Healthcare | 5.99% |
| 5 | Consumer Staples | 2.01% |
Similar funds
Draper Asset Management's Q2 2023 Portfolio in Review
As of Q2 2023, Draper Asset Management held 46 positions worth $100M, up 28% from $78.3M the previous quarter. Its ten largest holdings account for 92% of the portfolio.
Draper Asset Management withdrew a net $16.8M in Q2 2023, closing 10 positions and reducing 12 holdings. Its most notable exit was DocGo, an estimated $236K position sold in full.
By sector, the portfolio is most concentrated in Technology at 50% of assets, down from 52% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, Draper Asset Management opened a new position in Vertex Pharmaceuticals worth $1.73M.
- Draper Asset Management's largest Q2 2023 buy was Vertex Pharmaceuticals: 4,906 shares worth $1.73M.
- Draper Asset Management added most to Uber in Q2 2023, an estimated $865K increase.
- Draper Asset Management's biggest Q2 2023 reduction was Apple, cutting an estimated $889K.
- Draper Asset Management fully exited DocGo in Q2 2023, selling an estimated $236K.
- Draper Asset Management's ten largest holdings make up 92% of its $100M portfolio in Q2 2023.
- Draper Asset Management opened 9 new positions and closed 10 in Q2 2023.
- Draper Asset Management's portfolio value rose 28% quarter-over-quarter to $100M.
Based on Draper Asset Management's 13F filing for Q2 2023, filed 3 Aug 2023.